Unveiling the surgical risk associated with neoadjuvant chemotherapy in bladder cancer
BJU Int
.
2014 Aug;114(2):163-4.
doi: 10.1111/bju.12661.
Authors
Joaquim Bellmunt
1
,
Jeffrey J Leow
,
William Martin-Doyle
Affiliation
1
Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain.
PMID:
25070136
DOI:
10.1111/bju.12661
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antineoplastic Agents / administration & dosage*
Cystectomy / adverse effects*
Female
Humans
Male
Neoadjuvant Therapy / adverse effects*
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / surgery*
Substances
Antineoplastic Agents